Thomas Gießmann
- Pharmaceutical Science top 0.5%
- Drug Solubulity and Delivery Systems 2
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 9
- Drug-Induced Hepatotoxicity and Protection 3
- Gastroenterology top 2%
- Gastrointestinal motility and disorders 3
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 15
-
- Pharmacological Effects and Toxicity Studies 8
-
- Cholesterol and Lipid Metabolism 3
-
- HIV/AIDS drug development and treatment 3
- Co-authors
- Werner SiegmundWerner WeitschiesHubert MönnikesCarsten SchillerNorbert HostenR WarzokChristiane ModeßPeter Dazert
- Journals
- Clinical Pharmacology & Therapeutics (6 papers)The Journal of Clinical Pharmacology (2 papers)British Journal of Clinical Pharmacology (2 papers)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
Thomas Gießmann
33 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 113
- Pharmaceutical Science 480
- Pharmacology 379
- Gastroenterology 190
- Oncology 817
- Pediatrics, Perinatology and Child Health 511
Countries citing papers authored by Thomas Gießmann
This map shows the geographic impact of Thomas Gießmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gießmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gießmann more than expected).
Fields of papers citing papers by Thomas Gießmann
This network shows the impact of papers produced by Thomas Gießmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gießmann. The network helps show where Thomas Gießmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Gießmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2022 | 10 | |
| 3 | 2020 | 45 | |
| 4 | 2017 | 27 | |
| 5 | 2012 | 2 | |
| 6 | 2011 | 20 | |
| 7 | 2008 | 79 | |
| 8 | 2008 | 140 | |
| 9 | 2008 | 13 | |
| 10 | 2008 | 12 | |
| 11 | 2007 | 18 | |
| 12 | 2006 | 35 | |
| 13 | 2006 | 18 | |
| 14 | 2006 | 37 | |
| 15 | 2006 | 90 | |
| 16 | 2005 | 479 | |
| 17 | 2004 | 110 | |
| 18 | 2004 | 146 | |
| 19 | 2003 | 5 | |
| 20 | 1998 | 6 |
About Thomas Gießmann
Thomas Gießmann is a scholar working on Pharmacology, Oncology and Gastroenterology, having authored 33 papers that have together received 1.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (15 papers), Pharmacogenetics and Drug Metabolism (9 papers), Pharmacological Effects and Toxicity Studies (8 papers), Gastrointestinal motility and disorders (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Cholesterol and Lipid Metabolism (3 papers), HIV/AIDS drug development and treatment (3 papers) and Drug Solubulity and Delivery Systems (2 papers). The work is most often cited by research in Pharmaceutical Science (480 citations), Pharmacology (379 citations) and Gastroenterology (190 citations). Thomas Gießmann has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Werner Siegmund, Werner Weitschies, Hubert Mönnikes, Carsten Schiller, Norbert Hosten, R Warzok, Christiane Modeß, Peter Dazert, Heyo K. Kroemer and Eike Schroeder. Their work appears in journals such as Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.